Publications

You can use the filters to show only results that match your interests

Filter publications
350 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Advertising investigations: August 2017

  2. Suspended and revoked licences for manufacturers and wholesalers of medicines

  3. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  4. Guidance on applying human factors to medical devices

    • MHRA
    • Guidance
  5. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  6. Parallel import licenses granted in August 2017

    • MHRA
    • Decision
  7. Human and veterinary medicines: register of licensed wholesale distribution sites

  8. Human and veterinary medicines: register of licensed manufacturing sites 2017

  9. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  10. Medicines: new manufacturing and wholesale dealer licences

  11. Register of brokers authorised to deal in human medicines

  12. Toolkit on the risks of valproate medicines in female patients

  13. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  14. Early access to medicines scheme (EAMS) scientific opinion: Alectinib as monotherapy for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC)

  15. Proposal to make Dovonex Psoriasis Ointment available from Pharmacies

    • MHRA
    • Consultation outcome
  16. MHRA: business impact target

    • MHRA
    • Research and analysis
  17. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  18. Marketing authorisations granted in July 2017

  19. Parallel import licences granted in July 2017

  20. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  21. Widening the availability of naloxone

    • DH, MHRA and PHE
    • Guidance
  22. Human Medicines Regulations 2012 Advisory Bodies annual report 2016

    • MHRA
    • Corporate report
  23. Good clinical practice inspection metrics

  24. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2016 to 2017

    • MHRA
    • Corporate report
  25. Proposal to make Arthriex 750mg and 1500mg film-coated tablets available from Pharmacies

    • MHRA
    • Closed consultation
  26. Marketing authorisations granted in June 2017

  27. Parallel import licenses granted in June 2017

  28. Classification of Nasonex Allergy Control Nasal Spray

    • MHRA
    • Consultation outcome
  29. Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

    • MHRA
    • Consultation outcome
  30. Proposal to make Maloff Protect 250mg/100mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  31. Notified bodies for medical devices

  32. Medical devices: UK notified bodies

  33. Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy

  34. Better consultations, better evidence

    • MHRA
    • Research and analysis
  35. Advertising investigations: May 2017

  36. Post-implementation Review of the Human Medicines Regulations 2012 (MLX 391)

    • MHRA
    • Closed consultation
  37. Parallel import licences granted in May 2017

  38. Marketing authorisations granted in May 2017

  39. MHRA: requests under the Freedom of Information Act (FOIA)

    • MHRA
    • FOI release
  40. Advertising investigations: April 2017